Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPTsc with SPAQ and DP+IVM in School-aged Children in Burkina Faso
NCT05946642Phase 3Unknown
- Sponsor
- Malaria Consortium
- Start
- Jul 2023
- Primary completion
- May 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulfadoxine, pyrimethamine, amodiaquine, dihydroartemisinin, piperaquine in malaria, sponsored by Malaria Consortium. Status: unknown.
02
Drugs
sulfadoxinepyrimethamineamodiaquinedihydroartemisininpiperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05946642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05946642.